These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 16972903)

  • 21. Increased CD4+CD25+Foxp3+ regulatory T cells in tolerance induced by portal venous injection.
    He F; Chen Z; Xu S; Cai M; Wu M; Li H; Chen X
    Surgery; 2009 Jun; 145(6):663-74. PubMed ID: 19486771
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes.
    Brillard E; Pallandre JR; Chalmers D; Ryffel B; Radlovic A; Seilles E; Rohrlich PS; Pivot X; Tiberghien P; Saas P; Borg C
    Exp Hematol; 2007 Mar; 35(3):416-25. PubMed ID: 17309822
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of CD4+CD25+ natural regulatory T cells in the inflammatory infiltrate of human chronic periodontitis.
    Cardoso CR; Garlet GP; Moreira AP; Júnior WM; Rossi MA; Silva JS
    J Leukoc Biol; 2008 Jul; 84(1):311-8. PubMed ID: 18451325
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD4(+)CD25(+)CD127(low/-) regulatory T cells express Foxp3 and suppress effector T cell proliferation and contribute to gastric cancers progression.
    Shen LS; Wang J; Shen DF; Yuan XL; Dong P; Li MX; Xue J; Zhang FM; Ge HL; Xu D
    Clin Immunol; 2009 Apr; 131(1):109-18. PubMed ID: 19153062
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Natural regulatory (CD4+CD25+FOXP+) T cells control the production of pro-inflammatory cytokines during Plasmodium chabaudi adami infection and do not contribute to immune evasion.
    Cambos M; Bélanger B; Jacques A; Roulet A; Scorza T
    Int J Parasitol; 2008 Feb; 38(2):229-38. PubMed ID: 17868677
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytokines in the generation and function of regulatory T cell subsets in leishmaniasis.
    Ghosh S; Roy K; Rajalingam R; Martin S; Pal C
    Cytokine; 2021 Nov; 147():155266. PubMed ID: 32888774
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Leishmania spp.: on the interactions they establish with antigen-presenting cells of their mammalian hosts.
    Antoine JC; Prina E; Courret N; Lang T
    Adv Parasitol; 2004; 58():1-68. PubMed ID: 15603761
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Immunopathogenesis of Leishmania infections].
    Yurdakul P
    Mikrobiyol Bul; 2005 Jul; 39(3):363-81. PubMed ID: 16358498
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Specific inhibition of lymphocyte-proliferation responses by adherent suppressor cells in diffuse cutaneous leishmaniasis.
    Petersen EA; Neva FA; Oster CN; Bogaert Diaz H
    N Engl J Med; 1982 Feb; 306(7):387-92. PubMed ID: 6460184
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of CD4(+)CD25(+) regulatory T cells in Leishmania infection.
    Belkaid Y
    Expert Opin Biol Ther; 2003 Sep; 3(6):875-85. PubMed ID: 12943446
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Parasitic disease as a cause of immunosuppression.
    Nussenzweig RS
    N Engl J Med; 1982 Feb; 306(7):423-4. PubMed ID: 6460186
    [No Abstract]   [Full Text] [Related]  

  • 32. Experimental cutaneous leishmaniasis. IV. Selective suppression of cell-mediated immunity during the response of guinea-pigs to infection with Leishmania enriettii.
    Bryceson AD; Bray RS; Dumonde DC
    Clin Exp Immunol; 1974 Feb; 16(2):189-202. PubMed ID: 4619877
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Subversion of host cell signalling by the protozoan parasite Leishmania.
    Gregory DJ; Olivier M
    Parasitology; 2005; 130 Suppl():S27-35. PubMed ID: 16281989
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current understandings on the immunology of leishmaniasis and recent developments in prevention and treatment.
    Roberts MT
    Br Med Bull; 2005; 75-76():115-30. PubMed ID: 16847165
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cutaneous leishmaniasis: immune complex formation and necrosis in the acute phase.
    Ridley MJ; Ridley DS
    Br J Exp Pathol; 1984 Jun; 65(3):327-36. PubMed ID: 6378241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Experimental cutaneous leishmaniasis: disseminated leishmaniasis in genetically susceptible and resistant mice.
    Scott PA; Farrell JP
    Am J Trop Med Hyg; 1982 Mar; 31(2):230-8. PubMed ID: 6462064
    [No Abstract]   [Full Text] [Related]  

  • 37. Immune response to infection by Leishmania: A mathematical model.
    Siewe N; Yakubu AA; Satoskar AR; Friedman A
    Math Biosci; 2016 Jun; 276():28-43. PubMed ID: 26987853
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Leishmaniases: parasitic diseases of the immune system?].
    Shuĭkina EE
    Med Parazitol (Mosk); 1980; 49(6):16-22. PubMed ID: 7010105
    [No Abstract]   [Full Text] [Related]  

  • 39. The immune response to Leishmania: mechanisms of parasite control and evasion.
    Bogdan C; Röllinghoff M
    Int J Parasitol; 1998 Jan; 28(1):121-34. PubMed ID: 9504340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. T-cell tolerance as a potential effect of congenital leishmaniasis on offspring immunity.
    Galindo-Sevilla N; Mancilla-Ramírez J
    Parasite Immunol; 2019 Mar; 41(3):e12540. PubMed ID: 29888463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.